AstraZeneca launches K+ Connect initiative to strengthen hyperkalemia management
Pan-India multidisciplinary program aims to improve coordinated care for patients with chronic kidney disease and heart failure
Pan-India multidisciplinary program aims to improve coordinated care for patients with chronic kidney disease and heart failure
Approval for 5 mg and 10 mg strengths, bioequivalent to Farxiga®, strengthens Lupin’s anti-diabetic portfolio in US market
The new algorithm will be introduced as part of Roche’s CKD Algorithm Panelon thenavify Algorithm Suite
Subscribe To Our Newsletter & Stay Updated